Table 1 IRR for mental health disorders in people 10–24 years old by sex, age, deprivation and nationality
IRR 2022 vs. 2008 (the entire study period) | IRR 2013 vs. 2011 (peak period of economic crisis) | IRR 2020 vs. 2019 (lockdown/restriction of access to health services) | IRR 2022 vs. 2020 (pandemic period) | |||||
|---|---|---|---|---|---|---|---|---|
Depressive disorders | 2.44 (2.31–2.59) | 1.41 (1.32–1.50) | 0.88 (0.83–0.92) | 1.64 (1.56–1.72) | ||||
Anxiety disorders | 2.33 (2.27–2.39) | 1.28 (1.25–1.32) | 0.85 (0.83–0.87) | 1.46 (1.43–1.49) | ||||
Eating disorders | 3.29 (3.01–3.59) | 1.68 (1.54–1.84) | 1.16 (1.06–1.26) | 1.90 (1.77–2.04) | ||||
ADHD | 2.33 (2.17–2.50) | 1.18 (1.11–1.25) | 0.69 (0.64–0.74) | 2.22 (2.07–2.37) | ||||
IRR (95% CI) by sex, year 2022 | IRR (95% CI) by age group, year 2022 | IRR (95% CI) by deprivation quintiles, year 2022 | IRR (95% CI) by nationality, year 2022 | |||||
|---|---|---|---|---|---|---|---|---|
Depressive disorders | Boys | 1.00 | 10–14 y/o | 1.00 | Q5 (most deprived) | 1.00 | Spain | 1.00 |
Girls | 2.08 (1.96–2.22) | 15–18 y/o | 1.25 (1.15–1.36) | Q4 | 0.93 (0.84–1.04) | Americas | 1.50 (1.35–1.68) | |
19–24 y/o | 1.52 (1.41–1.63) | Q3 | 0.98 (0.88–1.09) | Africa | 0.56 (0.46–0.67) | |||
Q2 | 0.98 (0.88–1.09) | Asia and Oceania | 0.45 (0.35–0.58) | |||||
Q1 (least deprived) | 0.87 (0.79–0.97) | Other European | 0.90 (0.76–1.07) | |||||
Anxiety disorders | Boys | 1.00 | 10–14 y/o | 1.00 | Q5 (most deprived) | 1.00 | Spain | 1.00 |
Girls | 2.07 (2.01–2.13) | 15–18 y/o | 1.59 (1.53–1.66) | Q4 | 1.00 (0.96–1.05) | Americas | 1.59 (1.52–1.67) | |
19–24 y/o | 2.25 (2.18–2.33) | Q3 | 0.96 (0.92–1.01) | Africa | 0.74 (0.69–0.80) | |||
Q2 | 0.87 (0.83–0.91) | Asia and Oceania | 0.43 (0.38–0.48) | |||||
Q1 (least deprived) | 0.70 (0.67–0.73) | Other European | 1.05 (0.97–1.12) | |||||
Eating disorders | Boys | 1.00 | 10–14 y/o | 1.00 | Q5 (most deprived) | 1.00 | Spain | 1.00 |
Girls | 8.96 (7.87–10.21) | 15–18 y/o | 1.16 (1.06–1.28) | Q4 | 1.15 (0.99–1.33) | Americas | 0.84 (0.69–1.01) | |
19–24 y/o | 0.41 (0.37–0.46) | Q3 | 1.16 (1.00–1.35) | Africa | 0.26 (0.18–0.37) | |||
Q2 | 1.23 (1.06–1.43) | Asia and Oceania | 0.25 (0.16–0.39) | |||||
Q1 (least deprived) | 1.09 (0.94–1.27) | Other European | 0.80 (0.63–1.01) | |||||
Attention deficit and hyperactivity disorder | Boys | 1.00 | 10–14 y/o | 1.00 | Q5 (most deprived) | 1.00 | Spain | 1.00 |
Girls | 0.54 (0.50–0.58) | 15–18 y/o | 0.39 (0.36–0.43) | Q4 | 1.07 (0.92–1.23) | Americas | 0.80 (0.67–0.95) | |
19–24 y/o | 0.16 (0.14–0.18) | Q3 | 1.01 (0.87–1.17) | Africa | 0.37 (0.29–0.49) | |||
Q2 | 1.08 (0.94–1.25) | Asia and Oceania | 0.16 (0.10–0.27) | |||||
Q1 (least deprived) | 1.38 (1.20–1.60) | Other European | 0.68 (0.54–0.86) | |||||